 | • レポートコード：MRC2-11QY01761 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインテグリンベータ3のグローバル市場について調査・分析したレポートです。種類別（MSP-68、OCU-200、AC-301、C-16Y、その他）市場規模、用途別（黒色腫、動脈血栓症、糖尿病性黄斑浮腫、肺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インテグリンベータ3の競争状況、市場シェア ・世界のインテグリンベータ3市場：種類別市場規模 2015年-2020年（MSP-68、OCU-200、AC-301、C-16Y、その他） ・世界のインテグリンベータ3市場：種類別市場規模予測 2021年-2026年（MSP-68、OCU-200、AC-301、C-16Y、その他） ・世界のインテグリンベータ3市場：用途別市場規模 2015年-2020年（黒色腫、動脈血栓症、糖尿病性黄斑浮腫、肺がん、その他） ・世界のインテグリンベータ3市場：用途別市場規模予測 2021年-2026年（黒色腫、動脈血栓症、糖尿病性黄斑浮腫、肺がん、その他） ・北米のインテグリンベータ3市場分析：米国、カナダ ・ヨーロッパのインテグリンベータ3市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインテグリンベータ3市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインテグリンベータ3市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインテグリンベータ3市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Factor Therapeutics Ltd、Merck & Co Inc、SciFluor Life Sciences LLC、SOM Biotech SL、Vascular Pharmaceuticals Inc、VDDI Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Integrin Beta 3 Market
The global Integrin Beta 3 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Integrin Beta 3 Scope and Market Size
Integrin Beta 3 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Integrin Beta 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Integrin Beta 3 market is segmented into
MSP-68
OCU-200
AC-301
C-16Y
Others
Segment by Application, the Integrin Beta 3 market is segmented into
Melanoma
Arterial Thrombosis
Diabetic Macular Edema
Lung Cancer
Others
Regional and Country-level Analysis
The Integrin Beta 3 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Integrin Beta 3 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Integrin Beta 3 Market Share Analysis
Integrin Beta 3 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Integrin Beta 3 business, the date to enter into the Integrin Beta 3 market, Integrin Beta 3 product introduction, recent developments, etc.
The major vendors covered:
Factor Therapeutics Ltd
Merck & Co Inc
SciFluor Life Sciences LLC
SOM Biotech SL
Vascular Pharmaceuticals Inc
VDDI Pharmaceuticals
…
1 Study Coverage
1.1 Integrin Beta 3 Product Introduction
1.2 Market Segments
1.3 Key Integrin Beta 3 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Integrin Beta 3 Market Size Growth Rate by Type
1.4.2 MSP-68
1.4.3 OCU-200
1.4.4 AC-301
1.4.5 C-16Y
1.4.6 Others
1.5 Market by Application
1.5.1 Global Integrin Beta 3 Market Size Growth Rate by Application
1.5.2 Melanoma
1.5.3 Arterial Thrombosis
1.5.4 Diabetic Macular Edema
1.5.5 Lung Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Integrin Beta 3 Market Size, Estimates and Forecasts
2.1.1 Global Integrin Beta 3 Revenue 2015-2026
2.1.2 Global Integrin Beta 3 Sales 2015-2026
2.2 Global Integrin Beta 3, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Integrin Beta 3 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Integrin Beta 3 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Integrin Beta 3 Competitor Landscape by Players
3.1 Integrin Beta 3 Sales by Manufacturers
3.1.1 Integrin Beta 3 Sales by Manufacturers (2015-2020)
3.1.2 Integrin Beta 3 Sales Market Share by Manufacturers (2015-2020)
3.2 Integrin Beta 3 Revenue by Manufacturers
3.2.1 Integrin Beta 3 Revenue by Manufacturers (2015-2020)
3.2.2 Integrin Beta 3 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Integrin Beta 3 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Integrin Beta 3 Revenue in 2019
3.2.5 Global Integrin Beta 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Integrin Beta 3 Price by Manufacturers
3.4 Integrin Beta 3 Manufacturing Base Distribution, Product Types
3.4.1 Integrin Beta 3 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Integrin Beta 3 Product Type
3.4.3 Date of International Manufacturers Enter into Integrin Beta 3 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Integrin Beta 3 Market Size by Type (2015-2020)
4.1.1 Global Integrin Beta 3 Sales by Type (2015-2020)
4.1.2 Global Integrin Beta 3 Revenue by Type (2015-2020)
4.1.3 Integrin Beta 3 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Integrin Beta 3 Market Size Forecast by Type (2021-2026)
4.2.1 Global Integrin Beta 3 Sales Forecast by Type (2021-2026)
4.2.2 Global Integrin Beta 3 Revenue Forecast by Type (2021-2026)
4.2.3 Integrin Beta 3 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Integrin Beta 3 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Integrin Beta 3 Market Size by Application (2015-2020)
5.1.1 Global Integrin Beta 3 Sales by Application (2015-2020)
5.1.2 Global Integrin Beta 3 Revenue by Application (2015-2020)
5.1.3 Integrin Beta 3 Price by Application (2015-2020)
5.2 Integrin Beta 3 Market Size Forecast by Application (2021-2026)
5.2.1 Global Integrin Beta 3 Sales Forecast by Application (2021-2026)
5.2.2 Global Integrin Beta 3 Revenue Forecast by Application (2021-2026)
5.2.3 Global Integrin Beta 3 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Integrin Beta 3 by Country
6.1.1 North America Integrin Beta 3 Sales by Country
6.1.2 North America Integrin Beta 3 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Integrin Beta 3 Market Facts & Figures by Type
6.3 North America Integrin Beta 3 Market Facts & Figures by Application
7 Europe
7.1 Europe Integrin Beta 3 by Country
7.1.1 Europe Integrin Beta 3 Sales by Country
7.1.2 Europe Integrin Beta 3 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Integrin Beta 3 Market Facts & Figures by Type
7.3 Europe Integrin Beta 3 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Integrin Beta 3 by Region
8.1.1 Asia Pacific Integrin Beta 3 Sales by Region
8.1.2 Asia Pacific Integrin Beta 3 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Integrin Beta 3 Market Facts & Figures by Type
8.3 Asia Pacific Integrin Beta 3 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Integrin Beta 3 by Country
9.1.1 Latin America Integrin Beta 3 Sales by Country
9.1.2 Latin America Integrin Beta 3 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Integrin Beta 3 Market Facts & Figures by Type
9.3 Central & South America Integrin Beta 3 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Integrin Beta 3 by Country
10.1.1 Middle East and Africa Integrin Beta 3 Sales by Country
10.1.2 Middle East and Africa Integrin Beta 3 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Integrin Beta 3 Market Facts & Figures by Type
10.3 Middle East and Africa Integrin Beta 3 Market Facts & Figures by Application
11 Company Profiles
11.1 Factor Therapeutics Ltd
11.1.1 Factor Therapeutics Ltd Corporation Information
11.1.2 Factor Therapeutics Ltd Description and Business Overview
11.1.3 Factor Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Factor Therapeutics Ltd Integrin Beta 3 Products Offered
11.1.5 Factor Therapeutics Ltd Related Developments
11.2 Merck & Co Inc
11.2.1 Merck & Co Inc Corporation Information
11.2.2 Merck & Co Inc Description and Business Overview
11.2.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck & Co Inc Integrin Beta 3 Products Offered
11.2.5 Merck & Co Inc Related Developments
11.3 SciFluor Life Sciences LLC
11.3.1 SciFluor Life Sciences LLC Corporation Information
11.3.2 SciFluor Life Sciences LLC Description and Business Overview
11.3.3 SciFluor Life Sciences LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 SciFluor Life Sciences LLC Integrin Beta 3 Products Offered
11.3.5 SciFluor Life Sciences LLC Related Developments
11.4 SOM Biotech SL
11.4.1 SOM Biotech SL Corporation Information
11.4.2 SOM Biotech SL Description and Business Overview
11.4.3 SOM Biotech SL Sales, Revenue and Gross Margin (2015-2020)
11.4.4 SOM Biotech SL Integrin Beta 3 Products Offered
11.4.5 SOM Biotech SL Related Developments
11.5 Vascular Pharmaceuticals Inc
11.5.1 Vascular Pharmaceuticals Inc Corporation Information
11.5.2 Vascular Pharmaceuticals Inc Description and Business Overview
11.5.3 Vascular Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Vascular Pharmaceuticals Inc Integrin Beta 3 Products Offered
11.5.5 Vascular Pharmaceuticals Inc Related Developments
11.6 VDDI Pharmaceuticals
11.6.1 VDDI Pharmaceuticals Corporation Information
11.6.2 VDDI Pharmaceuticals Description and Business Overview
11.6.3 VDDI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 VDDI Pharmaceuticals Integrin Beta 3 Products Offered
11.6.5 VDDI Pharmaceuticals Related Developments
11.1 Factor Therapeutics Ltd
11.1.1 Factor Therapeutics Ltd Corporation Information
11.1.2 Factor Therapeutics Ltd Description and Business Overview
11.1.3 Factor Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Factor Therapeutics Ltd Integrin Beta 3 Products Offered
11.1.5 Factor Therapeutics Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Integrin Beta 3 Market Estimates and Projections by Region
12.1.1 Global Integrin Beta 3 Sales Forecast by Regions 2021-2026
12.1.2 Global Integrin Beta 3 Revenue Forecast by Regions 2021-2026
12.2 North America Integrin Beta 3 Market Size Forecast (2021-2026)
12.2.1 North America: Integrin Beta 3 Sales Forecast (2021-2026)
12.2.2 North America: Integrin Beta 3 Revenue Forecast (2021-2026)
12.2.3 North America: Integrin Beta 3 Market Size Forecast by Country (2021-2026)
12.3 Europe Integrin Beta 3 Market Size Forecast (2021-2026)
12.3.1 Europe: Integrin Beta 3 Sales Forecast (2021-2026)
12.3.2 Europe: Integrin Beta 3 Revenue Forecast (2021-2026)
12.3.3 Europe: Integrin Beta 3 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Integrin Beta 3 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Integrin Beta 3 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Integrin Beta 3 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Integrin Beta 3 Market Size Forecast by Region (2021-2026)
12.5 Latin America Integrin Beta 3 Market Size Forecast (2021-2026)
12.5.1 Latin America: Integrin Beta 3 Sales Forecast (2021-2026)
12.5.2 Latin America: Integrin Beta 3 Revenue Forecast (2021-2026)
12.5.3 Latin America: Integrin Beta 3 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Integrin Beta 3 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Integrin Beta 3 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Integrin Beta 3 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Integrin Beta 3 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Integrin Beta 3 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Integrin Beta 3 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Integrin Beta 3 Market Segments
Table 2. Ranking of Global Top Integrin Beta 3 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Integrin Beta 3 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of MSP-68
Table 5. Major Manufacturers of OCU-200
Table 6. Major Manufacturers of AC-301
Table 7. Major Manufacturers of C-16Y
Table 8. Major Manufacturers of Others
Table 9. Global Integrin Beta 3 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Integrin Beta 3 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Integrin Beta 3 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Integrin Beta 3 Sales Market Share by Regions (2015-2020)
Table 13. Global Integrin Beta 3 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Integrin Beta 3 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Integrin Beta 3 Sales Share by Manufacturers (2015-2020)
Table 16. Global Integrin Beta 3 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Integrin Beta 3 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Integrin Beta 3 as of 2019)
Table 18. Integrin Beta 3 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Integrin Beta 3 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Integrin Beta 3 Price (2015-2020) (USD/Pcs)
Table 21. Integrin Beta 3 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Integrin Beta 3 Product Type
Table 23. Date of International Manufacturers Enter into Integrin Beta 3 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Integrin Beta 3 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Integrin Beta 3 Sales Share by Type (2015-2020)
Table 27. Global Integrin Beta 3 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Integrin Beta 3 Revenue Share by Type (2015-2020)
Table 29. Integrin Beta 3 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Integrin Beta 3 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Integrin Beta 3 Sales Share by Application (2015-2020)
Table 32. North America Integrin Beta 3 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Integrin Beta 3 Sales Market Share by Country (2015-2020)
Table 34. North America Integrin Beta 3 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Integrin Beta 3 Revenue Market Share by Country (2015-2020)
Table 36. North America Integrin Beta 3 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Integrin Beta 3 Sales Market Share by Type (2015-2020)
Table 38. North America Integrin Beta 3 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Integrin Beta 3 Sales Market Share by Application (2015-2020)
Table 40. Europe Integrin Beta 3 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Integrin Beta 3 Sales Market Share by Country (2015-2020)
Table 42. Europe Integrin Beta 3 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Integrin Beta 3 Revenue Market Share by Country (2015-2020)
Table 44. Europe Integrin Beta 3 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Integrin Beta 3 Sales Market Share by Type (2015-2020)
Table 46. Europe Integrin Beta 3 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Integrin Beta 3 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Integrin Beta 3 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Integrin Beta 3 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Integrin Beta 3 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Integrin Beta 3 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Integrin Beta 3 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Integrin Beta 3 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Integrin Beta 3 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Integrin Beta 3 Sales Market Share by Application (2015-2020)
Table 56. Latin America Integrin Beta 3 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Integrin Beta 3 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Integrin Beta 3 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Integrin Beta 3 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Integrin Beta 3 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Integrin Beta 3 Sales Market Share by Type (2015-2020)
Table 62. Latin America Integrin Beta 3 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Integrin Beta 3 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Integrin Beta 3 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Integrin Beta 3 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Integrin Beta 3 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Integrin Beta 3 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Integrin Beta 3 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Integrin Beta 3 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Integrin Beta 3 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Integrin Beta 3 Sales Market Share by Application (2015-2020)
Table 72. Factor Therapeutics Ltd Corporation Information
Table 73. Factor Therapeutics Ltd Description and Major Businesses
Table 74. Factor Therapeutics Ltd Integrin Beta 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Factor Therapeutics Ltd Product
Table 76. Factor Therapeutics Ltd Recent Development
Table 77. Merck & Co Inc Corporation Information
Table 78. Merck & Co Inc Description and Major Businesses
Table 79. Merck & Co Inc Integrin Beta 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Merck & Co Inc Product
Table 81. Merck & Co Inc Recent Development
Table 82. SciFluor Life Sciences LLC Corporation Information
Table 83. SciFluor Life Sciences LLC Description and Major Businesses
Table 84. SciFluor Life Sciences LLC Integrin Beta 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. SciFluor Life Sciences LLC Product
Table 86. SciFluor Life Sciences LLC Recent Development
Table 87. SOM Biotech SL Corporation Information
Table 88. SOM Biotech SL Description and Major Businesses
Table 89. SOM Biotech SL Integrin Beta 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. SOM Biotech SL Product
Table 91. SOM Biotech SL Recent Development
Table 92. Vascular Pharmaceuticals Inc Corporation Information
Table 93. Vascular Pharmaceuticals Inc Description and Major Businesses
Table 94. Vascular Pharmaceuticals Inc Integrin Beta 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Vascular Pharmaceuticals Inc Product
Table 96. Vascular Pharmaceuticals Inc Recent Development
Table 97. VDDI Pharmaceuticals Corporation Information
Table 98. VDDI Pharmaceuticals Description and Major Businesses
Table 99. VDDI Pharmaceuticals Integrin Beta 3 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. VDDI Pharmaceuticals Product
Table 101. VDDI Pharmaceuticals Recent Development
Table 102. Global Integrin Beta 3 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global Integrin Beta 3 Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global Integrin Beta 3 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global Integrin Beta 3 Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: Integrin Beta 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: Integrin Beta 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: Integrin Beta 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: Integrin Beta 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: Integrin Beta 3 Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: Integrin Beta 3 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: Integrin Beta 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: Integrin Beta 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: Integrin Beta 3 Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: Integrin Beta 3 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key Integrin Beta 3 Players
Table 120. Integrin Beta 3 Customers List
Table 121. Integrin Beta 3 Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Integrin Beta 3 Product Picture
Figure 2. Global Integrin Beta 3 Sales Market Share by Type in 2020 & 2026
Figure 3. MSP-68 Product Picture
Figure 4. OCU-200 Product Picture
Figure 5. AC-301 Product Picture
Figure 6. C-16Y Product Picture
Figure 7. Others Product Picture
Figure 8. Global Integrin Beta 3 Sales Market Share by Application in 2020 & 2026
Figure 9. Melanoma
Figure 10. Arterial Thrombosis
Figure 11. Diabetic Macular Edema
Figure 12. Lung Cancer
Figure 13. Others
Figure 14. Integrin Beta 3 Report Years Considered
Figure 15. Global Integrin Beta 3 Market Size 2015-2026 (US$ Million)
Figure 16. Global Integrin Beta 3 Sales 2015-2026 (K Pcs)
Figure 17. Global Integrin Beta 3 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Integrin Beta 3 Sales Market Share by Region (2015-2020)
Figure 19. Global Integrin Beta 3 Sales Market Share by Region in 2019
Figure 20. Global Integrin Beta 3 Revenue Market Share by Region (2015-2020)
Figure 21. Global Integrin Beta 3 Revenue Market Share by Region in 2019
Figure 22. Global Integrin Beta 3 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Integrin Beta 3 Revenue in 2019
Figure 24. Integrin Beta 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Integrin Beta 3 Sales Market Share by Type (2015-2020)
Figure 26. Global Integrin Beta 3 Sales Market Share by Type in 2019
Figure 27. Global Integrin Beta 3 Revenue Market Share by Type (2015-2020)
Figure 28. Global Integrin Beta 3 Revenue Market Share by Type in 2019
Figure 29. Global Integrin Beta 3 Market Share by Price Range (2015-2020)
Figure 30. Global Integrin Beta 3 Sales Market Share by Application (2015-2020)
Figure 31. Global Integrin Beta 3 Sales Market Share by Application in 2019
Figure 32. Global Integrin Beta 3 Revenue Market Share by Application (2015-2020)
Figure 33. Global Integrin Beta 3 Revenue Market Share by Application in 2019
Figure 34. North America Integrin Beta 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Integrin Beta 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Integrin Beta 3 Sales Market Share by Country in 2019
Figure 37. North America Integrin Beta 3 Revenue Market Share by Country in 2019
Figure 38. U.S. Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Integrin Beta 3 Market Share by Type in 2019
Figure 43. North America Integrin Beta 3 Market Share by Application in 2019
Figure 44. Europe Integrin Beta 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Integrin Beta 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Integrin Beta 3 Sales Market Share by Country in 2019
Figure 47. Europe Integrin Beta 3 Revenue Market Share by Country in 2019
Figure 48. Germany Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Integrin Beta 3 Market Share by Type in 2019
Figure 59. Europe Integrin Beta 3 Market Share by Application in 2019
Figure 60. Asia Pacific Integrin Beta 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Integrin Beta 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Integrin Beta 3 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Integrin Beta 3 Revenue Market Share by Region in 2019
Figure 64. China Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Integrin Beta 3 Market Share by Type in 2019
Figure 87. Asia Pacific Integrin Beta 3 Market Share by Application in 2019
Figure 88. Latin America Integrin Beta 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Integrin Beta 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Integrin Beta 3 Sales Market Share by Country in 2019
Figure 91. Latin America Integrin Beta 3 Revenue Market Share by Country in 2019
Figure 92. Mexico Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Integrin Beta 3 Market Share by Type in 2019
Figure 99. Latin America Integrin Beta 3 Market Share by Application in 2019
Figure 100. Middle East and Africa Integrin Beta 3 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Integrin Beta 3 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Integrin Beta 3 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Integrin Beta 3 Revenue Market Share by Country in 2019
Figure 104. Turkey Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Integrin Beta 3 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Integrin Beta 3 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Integrin Beta 3 Market Share by Type in 2019
Figure 111. Middle East and Africa Integrin Beta 3 Market Share by Application in 2019
Figure 112. North America Integrin Beta 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Integrin Beta 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Integrin Beta 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Integrin Beta 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Integrin Beta 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Integrin Beta 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Integrin Beta 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Integrin Beta 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Integrin Beta 3 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Integrin Beta 3 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
インテグリンベータ1の世界市場（～2026年） Market Analysis and Insights: Global Integrin Beta 1 Market The global Integrin Beta 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Integrin Beta 1 Scope and Market Size Integrin Beta 1 market is segmented by Type, …- インテグリンアルファVの世界市場（～2026年） Market Analysis and Insights: Global Integrin Alpha V Market The global Integrin Alpha V market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Integrin Alpha V Scope and Market Size Integrin Alpha V market is segmented by Ty…
- トランスフォーミンググロースファクターベータ2の世界市場（～2026年） Market Analysis and Insights: Global Transforming Growth Factor Beta 2 Market The global Transforming Growth Factor Beta 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Transforming Growth Factor Beta 2 Scope and Mar…
- 糖尿病性黄斑浮腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Diabetic Macular Edema Drug Market The global Diabetic Macular Edema Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetic Macular Edema Drug Scope and Market Size Diabetic …
- 糖尿病性黄斑浮腫治療の世界市場（～2026年） Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Increasing prevalence of diabetes in the prime factor driving …